Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Nearly 1 in 5 cancer patients treated with cisplatin-based chemotherapy have a thromboembolic event within a month of ending treatment, according to a…
NEW YORK (Reuters Health) – Results of two phase II trials investigating the addition of bortezomib to combination treatments of follicular lymphoma suggest that the strategy is feasible…
NEW YORK (Reuters Health) – Radiofrequency ablation (RFA) is a viable alternative in patients with early hepatocellular carcinoma who are not candidates for surgery, Taiwanese researchers report in…
NEW YORK (Reuters Health) – Pneumothorax occurs in 15% of patients having a transthoracic needle biopsy of a pulmonary nodule, according to the findings of a population-based cross-sectional…
NEW YORK (Reuters Health) – When added to whole-brain irradiation, radiosurgery is preferable to neurosurgical resection for treating cancer patients with a single metastasis to the brain, according…
NEW YORK (Reuters Health) – Epoetin alpha can reduce the number of erythrocyte transfusions needed in patients with acute leukemia undergoing myelosuppressive chemotherapy, without affecting length of remission,…
NEW YORK (Reuters Health) – A new study suggests that, in a real-world setting, adjuvant chemotherapy in adults over age 65 with stage II colon cancer and high-risk…
NEW YORK (Reuters Health) – No chemotherapy sensitivity and resistance assays have sufficient supporting evidence to justify their use in oncology practice. That’s the conclusion of an American…
NEW YORK (Reuters Health) – In women undergoing breast-conserving therapy for early breast cancer, the presence of occult metastasis not seen with routine pathological examination in sentinel lymph…
NEW YORK (Reuters Health) – In young women with breast cancer, temporary ovarian suppression by the gonadotropin-releasing hormone analogue triptorelin during chemotherapy reduces the occurrence of premature menopause,…
